Copied
 
 
Formål
HistorikStartStop
Selskabets formål er at lave kontraktforskning for Pharmaceutisk, Biotech og Medical Device industri22.03.201303.02.2022
Virksomheden har ikke ændret Formål i sin levetid.
Ingen nuværende registrering.
Status
HistorikStartStop
OPLØST EFTER KONKURS03.02.202203.02.2022
UNDER KONKURS09.06.202002.02.2022
UNDER FRIVILLIG LIKVIDATION25.03.202008.06.2020
NORMAL18.11.201924.03.2020
UNDER TVANGSOPLØSNING08.10.201917.11.2019
NORMAL02.04.200307.10.2019
Ingen nuværende registrering.
Branche
HistorikStartStop
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)01.01.200803.02.2022
Forskning og udvikling inden for naturvidenskab og teknik (731000)02.04.200331.12.2007
Ingen nuværende registrering.
Revision
HistorikStartStop
false02.04.200303.02.2022
Virksomheden har ikke ændret Revision i sin levetid.
Ingen nuværende registrering.
Form
HistorikStartStop
6002.04.200303.02.2022
Virksomheden har ikke ændret Form i sin levetid.
Ingen nuværende registrering.
Kontakt
Ingen nuværende registrering.
Ingen historik.
Telefon
HistorikStartStop
4516880007.11.201803.04.2020
Virksomheden har ikke ændret Telefon i sin levetid.
Ingen nuværende registrering.
Navne
Ingen nuværende registrering.
Binavne
HistorikStartStop
ACRONORDIC A/S02.04.200305.07.2016
Virksomheden har ikke ændret Binavne i sin levetid.
Ingen nuværende registrering.
Tegningsregel
HistorikStartStop
Virksomheden tegnes af en likvidator25.03.202009.06.2020
Selskabet tegnes af direktøren, et bestyrelsesmedlem eller af den samlede bestyrelse12.11.201924.03.2020
Selskabet tegnes af direktøren, et bestyrelsesmedlem eller af den samlede bestyrelse22.03.201308.10.2019
Ingen nuværende registrering.
Ansatte
14.05.2024
Kapital
14.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor's responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):We have audited the financial statements of Navitas Life Sciences A/S for the financial year 1 April 2018 - 31 March 2019, which comprise income statement, balance sheet, statement of changes in equity, notes and summary of significant accounting policies. The financial statements are prepared under the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the company's financial position at 31 March 2019 and of the results of the company's operations for the financial year 1 April 2018 - 31 March 2019 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on management's review Management is responsible for management's review. Our opinion on the financial statements døs not cover management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read management's review and, in doing so, consider whether management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
14.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
14.05.2024
Ingen nuværende registrering.
Ingen historik.